Celldex Therapeutics, Inc. Share Price Today: Live Updates & Key Insights
Celldex Therapeutics, Inc. share price today is $31.03, up 2.9%. The stock opened at $30.1 against the previous close of $30.03, with an intraday high of $31.81 and low of $30.01.
Celldex Therapeutics, Inc. Share Price Chart
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. Share Price Performance
Celldex Therapeutics, Inc. Institutional Holdings
Celldex Therapeutics, Inc. Market Status
Celldex Therapeutics, Inc. Fundamentals
Market Cap 2056.90 M
PB Ratio 3.792
PE Ratio 0.0
Enterprise Value 1482.75 M
Total Assets 582.98 M
Volume 3242637
Celldex Therapeutics, Inc. Company Financials
About Celldex Therapeutics, Inc. & investment objective
Company Information Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.
Organisation Biotechnology
Employees 198
Industry Biotechnology
CEO Mr. Anthony S. Marucci M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Celldex Therapeutics, Inc. FAQs
What is the share price of Celldex Therapeutics, Inc. today?
The current share price of Celldex Therapeutics, Inc. is $31.03.
Can I buy Celldex Therapeutics, Inc. shares in India?
Yes, Indian investors can buy Celldex Therapeutics, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Celldex Therapeutics, Inc. shares in India?
You can easily invest in Celldex Therapeutics, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Celldex Therapeutics, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Celldex Therapeutics, Inc..
Can I buy fractional shares of Celldex Therapeutics, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. has a market cap of $2056.90 M.
In which sector does Celldex Therapeutics, Inc. belong?
Celldex Therapeutics, Inc. operates in the Biotechnology sector.
What documents are required to invest in Celldex Therapeutics, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Celldex Therapeutics, Inc.?
The PE ratio of Celldex Therapeutics, Inc. is N/A and the PB ratio is 3.79.